Skip to main content

Together we are beating cancer

Donate now

In collaboration with PA Media Group

Showing 12 out of 356 results
Cancer Research UK logo

Italian researchers have shown that the effect of treating women before surgery with trastuzumab (Herceptin) and docetaxel for HER2-positive breast cancer is improved by adding another 'Herceptin-like' drug called pertuzumab. Italian researchers have shown that the effect of treating women before surgery with trastuzumab (Herceptin) and docetaxel for HER2-positive breast cancer is improved by adding another 'Herceptin-like' drug called pertuzumab.

by In collaboration with PA Media Group | News | 7 December 2011

7 December 2011

Cancer Research UK logo
  • Science & Technology
  • Health & Medicine

Scientists identify first genetic link to myeloma

For the first time researchers have identified genetic variations that influence a person's chances of developing a type of blood cancer called multiple myeloma, according to a British study part-funded by Cancer Research UK. For the first time researchers have identified genetic variations that influence a person's chances of developing a type of blood cancer called multiple myeloma, according to a British study part-funded by Cancer Research UK.

by In collaboration with PA Media Group | News | 27 November 2011

27 November 2011

Cancer Research UK logo

Long-term aspirin use protects against bowel cancer in people with Lynch syndrome - a genetic disorder that predisposes to the disease - according to research partly funded by Cancer Research UK. Long-term aspirin use protects against bowel cancer in people with Lynch syndrome - a genetic disorder that predisposes to the disease - according to research partly funded by Cancer Research UK.

by In collaboration with PA Media Group | News | 28 October 2011

28 October 2011

Cancer Research UK logo

In the largest study of its kind, Danish researchers have found that the rates of oesophageal cancer among people with Barrett's oesophagus - a common condition that predisposes to the disease - could be up to four times lower than previous estimates. In the largest study of its kind, Danish researchers have found that the rates of oesophageal cancer among people with Barrett's oesophagus - a common condition that predisposes to the disease - could be up to four times lower than previous estimates.

by In collaboration with PA Media Group | News | 13 October 2011

13 October 2011

Cancer Research UK logo

Cancer Research UK's patient information website, CancerHelp UK, and its health information leaflets have been awarded the Department of Health Information Standard. Cancer Research UK's patient information website, CancerHelp UK, and its health information leaflets have been awarded the Department of Health Information Standard.

by In collaboration with PA Media Group | News | 22 December 2009

22 December 2009

Cancer Research UK logo

Cancer Research UK scientists have found that a combination of chemotherapy and radiotherapy improves survival from advanced head and neck cancer in patients who are not able to have surgery. Cancer Research UK scientists have found that a combination of chemotherapy and radiotherapy improves survival from advanced head and neck cancer in patients who are not able to have surgery.

by In collaboration with PA Media Group | News | 30 October 2009

30 October 2009

Cancer Research UK logo

Leading health organisations, including Cancer Research UK, have welcomed MPs' decision to include an outright ban on cigarette vending machines in the Health Bill. Leading health organisations, including Cancer Research UK, have welcomed MPs' decision to include an outright ban on cigarette vending machines in the Health Bill.

by In collaboration with PA Media Group | News | 13 October 2009

13 October 2009

Cancer Research UK logo

Scientists have developed a new bone marrow transplant technique that only requires a small dose of chemotherapy and may therefore make treatment safer and less distressing for children with genetic defects in their immune system (primary immunodeficiencies or PID). Scientists have developed a new bone marrow transplant technique that only requires a small dose of chemotherapy and may therefore make treatment safer and less distressing for children with genetic defects in their immune system (primary immunodeficiencies or PID).

by In collaboration with PA Media Group | News | 4 September 2009

4 September 2009